"Designing Growth Strategies is in our DNA"

U.S. Immunoglobulin Market Size, Share & Industry Analysis, By Product Type (Intravenous Immunoglobulin (IVIG) {Primary Immunodeficiency, Secondary Immunodeficiency, Chronic Inflammatory Demyelinating Polyneuropathy, Guillain-Barré Syndrome, Immune Thrombocytopenic Purpura, Multifocal Motor Neuropathy, and Others}, and Subcutaneous Immunoglobulin (SCIG) {Primary Immunodeficiency, Secondary Immunodeficiency, Chronic Inflammatory Demyelinating Polyneuropathy, and Others}), By Form (Liquid and Lyophilized), By End User (Hospitals, Clinics, and Homecare), and Country Forecast, 2026-2034

Last Updated: March 09, 2026 | Format: PDF | Report ID: FBI108226

 

We will customize the report to meet your research goals, helping you gain a competitive edge, and make informed decisions.

  1. Introduction
    1. Research Scope
    2. Market Segmentation
    3. Research Methodology
    4. Definitions and Assumptions
  2. Executive Summary
  3. Market Dynamics
    1. Market Drivers
    2. Market Restraints
    3. Market Opportunities
    4. Market Trends
  4. Key Insights
    1. Pipeline Analysis, By Key Players
    2. Key Industry Developments (Mergers, Acquisitions, etc.)
    3. New Product Launches, By Key Players
    4. Overview of Regulatory & Reimbursement Scenario, in U.S.
    5. Prevalence of Major Diseases, in U.S.
  5. U.S. Immunoglobulin Market Analysis, Insights and Forecast, 2021-2034
    1. Market Analysis, Insights and Forecast – By Product Type
      1. Intravenous Immunoglobulin (IVIG)
        1. Primary Immunodeficiency
        2. Secondary Immunodeficiency
        3. Chronic Inflammatory Demyelinating Polyneuropathy
        4. Guillain-Barré Syndrome
        5. Immune Thrombocytopenic Purpura
        6. Multifocal Motor Neuropathy
        7. Others
      2. Subcutaneous Immunoglobulin (SCIG)
        1. Primary Immunodeficiency
        2. Secondary Immunodeficiency
        3. Chronic Inflammatory Demyelinating Polyneuropathy
        4. Others
    2. Market Analysis, Insights and Forecast – By Form
      1. Liquid
      2. Lyophilized
    3. Market Analysis, Insights and Forecast – By End User
      1. Hospitals
      2. Clinics
      3. Homecare
    4. Market Analysis, Insights and Forecast – Region
      1. North America
      2. Europe
      3. Asia Pacific
      4. Latin America
      5. Middle East & Africa
  6. Competitive Analysis
    1. U.S. Market Share Analysis (2025)
    2. Company Profiles (Overview, Products, SWOT analysis, Recent developments, strategies, financials (based on availability)
      1. CSL
      2. Takeda Pharmaceutical Company Limited
      3. Grifols, S.A.
      4. Kedrion S.p.A
      5. Octapharma AG
      6. ADMA Biologics, Inc.
      7. Taibang Biologic Group (China Biologic Products Holdings, Inc.)
      8. LFB Group
      9. Shanghai RAAS Blood Products Co., Ltd
      10. GC Biopharma Corp.
  1. Introduction
    1. Research Scope
    2. Market Segmentation
    3. Research Methodology
    4. Definitions and Assumptions
  2. Executive Summary
  3. Market Dynamics
    1. Market Drivers
    2. Market Restraints
    3. Market Opportunities
    4. Market Trends
  4. Key Insights
    1. Pipeline Analysis, By Key Players
    2. Key Industry Developments (Mergers, Acquisitions, etc.)
    3. New Product Launches, By Key Players
    4. Overview of Regulatory & Reimbursement Scenario, in U.S.
    5. Prevalence of Major Diseases, in U.S.
  5. U.S. Immunoglobulin Market Analysis, Insights and Forecast, 2021-2034
    1. Market Analysis, Insights and Forecast – By Product Type
      1. Intravenous Immunoglobulin (IVIG)
        1. Primary Immunodeficiency
        2. Secondary Immunodeficiency
        3. Chronic Inflammatory Demyelinating Polyneuropathy
        4. Guillain-Barré Syndrome
        5. Immune Thrombocytopenic Purpura
        6. Multifocal Motor Neuropathy
        7. Others
      2. Subcutaneous Immunoglobulin (SCIG)
        1. Primary Immunodeficiency
        2. Secondary Immunodeficiency
        3. Chronic Inflammatory Demyelinating Polyneuropathy
        4. Others
    2. Market Analysis, Insights and Forecast – By Form
      1. Liquid
      2. Lyophilized
    3. Market Analysis, Insights and Forecast – By End User
      1. Hospitals
      2. Clinics
      3. Homecare
    4. Market Analysis, Insights and Forecast – Region
      1. North America
      2. Europe
      3. Asia Pacific
      4. Latin America
      5. Middle East & Africa
  6. Competitive Analysis
    1. U.S. Market Share Analysis (2025)
    2. Company Profiles (Overview, Products, SWOT analysis, Recent developments, strategies, financials (based on availability)
      1. CSL
      2. Takeda Pharmaceutical Company Limited
      3. Grifols, S.A.
      4. Kedrion S.p.A
      5. Octapharma AG
      6. ADMA Biologics, Inc.
      7. Taibang Biologic Group (China Biologic Products Holdings, Inc.)
      8. LFB Group
      9. Shanghai RAAS Blood Products Co., Ltd
      10. GC Biopharma Corp.
Read Less

Figure 1:  U.S. Immunoglobulin Market Value (USD billion), by Product Type 2025 & 2032

Figure 2:  U.S. Immunoglobulin Market Value Share (%), by Product Type 2025

Figure 3:  U.S. Immunoglobulin Market Value (USD billion), by Form, 2025 & 2032

Figure 4:  U.S. Immunoglobulin Market Value Share (%), by Form, 2025

Figure 5:  U.S. Immunoglobulin Market Value (USD billion), by End User, 2025 & 2032

Figure 6:  U.S. Immunoglobulin Market Value Share (%), by End User, 2025

Table 1:  U.S. Immunoglobulin Market Revenue (USD billion) Forecast, by Product Type, 2021–2034

Table 2:  U.S. Immunoglobulin Market Revenue (USD billion) Forecast, by Intravenous Immunoglobulin (IVIG), 2021–2034

Table 3:  U.S. Immunoglobulin Market Revenue (USD billion) Forecast, by Subcutaneous Immunoglobulin (SCIG), 2021–2034

Table 4:  U.S. Immunoglobulin Market Revenue (USD billion) Forecast, by Form, 2021–2034

Table 5:  U.S. Immunoglobulin Market Revenue (USD billion) Forecast, by End User, 2021–2034

U.S. Immunoglobulin Market
  • 2021-2034
  • 2025
  • 2021-2024
  • 60
Download Free Sample

    man icon
    Mail icon
    Captcha refresh

Get 20% Free Customization

Expand Regional and Country Coverage, Segments Analysis, Company Profiles, Competitive Benchmarking, and End-user Insights.

Get 20% Free Customization On This Report
Growth Advisory Services
    How can we help you uncover new opportunities and scale faster?
Clients
3M
Toshiba
Fresenius
Johnson
Siemens
Abbot
Allergan
American Medical Association
Becton, Dickinson and Company
Bristol-Myers Squibb Company
Henry Schein
Mckesson
Mindray
National Institutes of Health (NIH)
Nihon Kohden
Olympus
Quest Diagnostics
Sanofi
Smith & Nephew
Straumann

Related Reports